alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]

RxCUI
1013867
RxNorm name
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Display name
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Full name
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125325GlassiaAlpha-1-Proteinase Inhibitor (Human)351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GLASSIAALPHA.1-PROTEINASE INHIBITOR HUMANTakeda Pharmaceuticals America, Inc.83473cbb-48e4-42a2-81b6-4c851423da7b2025-12-02Warnings, Adverse reactionsExact identifier
rxcui: 1013867

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
83473cbb-48e4-42a2-81b6-4c851423da7bGlassia 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia] [SBD] · Glassia 1 MG Injection [SY]331These highlights do not include all the information needed to use GLASSIA safely and effectively. See full prescribing information for GLASSIA. GLASSIA ® (Alpha 1 -Proteinase Inhibitor (Human)) Injection, For Intravenous Use Initial U.S. Approval: 201020251202